(mh=sw_GS7dEDCl0bLM6)9.jpg "Mallia Aesthetics Reports Positive Results from Consumer Study with its Hormone-Free 8T3 Essentials Hair Serum | Corporate")
Mallia Aesthetics Reports Positive Results from Consumer Study with its Hormone-Free 8T3 Essentials Hair Serum | Corporate
Mallia Aesthetics GmbH reported on June 18, 2026, that 87% of participants in a six-month consumer study experienced positive results using its hormone-free 8T3 Essentials Hair Serum. The study, which evaluated 23 volunteers, found that 70% of users observed new hair growth, while average hair density across the group increased by 30%.
Study Outcomes and Methodology
The research, which utilized imaging systems from TrichoLAB and Canfield Scientific, focused on a user population with a mean age of 52 years and an average baseline hair density of 96 hairs/cm². According to Mallia Aesthetics, 17% of participants reported that their hair loss stopped entirely during the trial. Some individuals, categorized by the company as “super-responders,” saw hair density gains of up to 193%.
Participant feedback aligned with the objective imaging data. Questionnaires revealed that 95% of users observed a reduction or total cessation of hair loss, while 80% reported new hair growth. All 23 participants stated the serum was well-tolerated and confirmed they would recommend the product to others.
The active ingredient in the 8T3 Essentials serum, MAL-838, is based on the sCD83 protein, which was first identified in 2001 by Mallia co-founder Prof. Dr. Alexander Steinkasserer.
Mechanism of Action
Unlike traditional hormone-free hair growth products that primarily focus on blood flow and nutrient delivery, the 8T3 Essentials serum targets the inflammatory environment of the hair follicle. Prof. Dr. Steinkasserer stated that the sCD83 protein is designed to resolve inflammation and protect follicles from premature cell death. The serum functions by activating follicular stem cells and inducing keratin production without entering the bloodstream or affecting systemic hormone levels.
The reliance on a localized, immunomodulatory approach represents a shift from systemic treatments, which often carry a higher risk of side effects. By targeting the inflammatory microenvironment of the follicle, this method aims to support the natural hair growth cycle through direct, topical application rather than internal intervention.
Future Commercial Outlook
The 8T3 Essentials Hair Serum is currently available for purchase throughout the European Union via the company’s official webshop. While the current distribution is limited to the EU, Mallia Innovations has indicated plans to expand its commercial activities into additional markets in the future. The company continues to develop its sCD83-based portfolio, including clinical-stage investigations for androgenetic alopecia and alopecia areata.
Frequently Asked Questions
How often must the 8T3 Essentials Hair Serum be applied?
According to Mallia Aesthetics, the serum is a light, watery formula that requires application only twice per week.
Does the serum enter the bloodstream?
No. The company states that while the serum reaches the hair follicles upon topical application, it does not penetrate through the skin to enter the bloodstream, keeping the effect localized.
What types of hair loss is the product intended for?
The product is marketed as a cosmetic solution to stimulate hair growth. The underlying technology, sCD83, is also being researched by Mallia Therapeutics for clinical applications including androgenetic alopecia and alopecia areata.
Have you ever considered the role of inflammation in your own hair-care routine?